Literature DB >> 3957529

Severe measles in Sunderland, 1885: a European-African comparison of causes of severe infection.

P Aaby, J Bukh, I M Lisse, A J Smits.   

Abstract

On the basis of research in Guinea-Bissau, this paper re-analyses a severe measles epidemic which occurred in 1885 in Sunderland (England). In both England and Guinea-Bissau, acute measles mortality was higher in households with multiple cases than in families with only a single case of measles. Secondary cases (infected in the house) had higher mortality and higher frequency of severe complications than index and single cases. In Sunderland, severe complications were associated with a history of previous respiratory infection and with greater number of siblings. Since cases with severe complications had significantly prolonged prodromal symptoms and shorter periods of incubation, it is suggested that high dose of infection may be an essential mechanism in the pathogenesis of severe disease. Overcrowding may be a major determinant of severe measles because it increases the risks of intensive exposure, intercurrent infections, and previous respiratory infection.

Entities:  

Mesh:

Year:  1986        PMID: 3957529     DOI: 10.1093/ije/15.1.101

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  4 in total

Review 1.  Should measles be eradicated?

Authors:  F T Cutts; R Steinglass
Journal:  BMJ       Date:  1998-03-07

2.  Decline in measles mortality: nutrition, age at infection, or exposure?

Authors:  P Aaby; J Bukh; I M Lisse; M C da Silva
Journal:  Br Med J (Clin Res Ed)       Date:  1988-04-30

3.  Household-acquisition of measles and illness severity in an urban community in the United States.

Authors:  J C Butler; M E Proctor; K Fessler; D J Hopfensperger; D M Sosin; J P Davis
Journal:  Epidemiol Infect       Date:  1994-06       Impact factor: 2.451

Review 4.  Protection against severe infectious disease in the past.

Authors:  Alexander Mercer
Journal:  Pathog Glob Health       Date:  2021-02-11       Impact factor: 2.894

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.